Skip to main content
. Author manuscript; available in PMC: 2019 Oct 18.
Published in final edited form as: Biol Blood Marrow Transplant. 2018 Jan 2;24(5):964–972. doi: 10.1016/j.bbmt.2017.12.804

Table 5.

Multivariate Analysis Model of Risk Factors for Transplantation Outcomes in All Patients, Including the Merged Category of HCT Approach and Comorbidity Burden

Patient and Graft Characteristic NRM Relapse OS CRFS RFS
HR (95%CI) P value HR (95%CI) P value HR (95%CI) P value HR (95%CI) P value HR (95%CI) P value
Age (years) .055 .225 .005 .025 .003
 50–59 Reference Reference Reference Reference Reference
 >60 1.54 (.99–2.41) 1.31 (.85–2.03) 1.6 (1.16–2.22) 1.34 (1.04–1.74) 1.61 (1.18–2.19)
Donor .036 .694 .066 .169 .081
 Related Reference Reference Reference Reference Reference
 Nonrelated 1.61 (1.03–2.52) .95 (.59–1.41) 1.37 (.98–1.9) 1.2 (.92–1.57) 1.32 (.97–1.81)
Diagnosis .023
 AML Reference
 MDS 1.64 (1.07–2.5)
DRI - - <.001 <.001 <.001 <.001
 Low/intermediate Reference Reference Reference Reference
 High 3.33 (2.15–5.18) 2.22 (1.58–3.14) 1.94 (1.44–2.6) 2.3 (1.65–3.19)
HCT approach and HCT-CI .270 .018 .087 <.001 .047
 TCD and HCT-CI 0–2 Reference Reference Reference Reference Reference
 TCD and HCT-CI ≥ 3 1.57 (.9–2.75) 1.32 (.75–2.34) 1.49 (.96–2.29) 1.53 (1.03–2.27) 1.53 (1.02–2.3)
 RIC and HCT-CI 0–2 .95 (.49–1.85) 2.35 (1.31–4.2) 1.66 (1.05–2.63) 4.44 (3.03–6.53) 1.71 (1.11–2.66)
 RIC and HCT-CI ≥ 3 1.21 (.59–2.47) 2.13 (1.12–4.04) 1.81 (1.09–2.99) 5.05 (3.3–7.71) 1.82 (1.13-2.94)